guest ::
| Home > Publications Database > Depressive Symptoms and Amyloid Pathology. > print |
| 001 | 277426 | ||
| 005 | 20250323000946.0 | ||
| 024 | 7 | _ | |a 10.1001/jamapsychiatry.2024.4305 |2 doi |
| 024 | 7 | _ | |a pmid:39841452 |2 pmid |
| 024 | 7 | _ | |a pmc:PMC11883504 |2 pmc |
| 024 | 7 | _ | |a 2168-622X |2 ISSN |
| 024 | 7 | _ | |a 0003-990X |2 ISSN |
| 024 | 7 | _ | |a 0375-8532 |2 ISSN |
| 024 | 7 | _ | |a 1538-3636 |2 ISSN |
| 024 | 7 | _ | |a 2168-6238 |2 ISSN |
| 024 | 7 | _ | |a 2330-9636 |2 ISSN |
| 024 | 7 | _ | |a altmetric:173257015 |2 altmetric |
| 037 | _ | _ | |a DZNE-2025-00409 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Wiels, Wietse A |b 0 |
| 245 | _ | _ | |a Depressive Symptoms and Amyloid Pathology. |
| 260 | _ | _ | |a Chicago, Ill. |c 2025 |b AMA |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1742377671_22879 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Depressive symptoms are associated with cognitive decline in older individuals. Uncertainty about underlying mechanisms hampers diagnostic and therapeutic efforts. This large-scale study aimed to elucidate the association between depressive symptoms and amyloid pathology.To examine the association between depressive symptoms and amyloid pathology and its dependency on age, sex, education, and APOE genotype in older individuals without dementia.Cross-sectional analyses were performed using data from the Amyloid Biomarker Study data pooling initiative. Data from 49 research, population-based, and memory clinic studies were pooled and harmonized. The Amyloid Biomarker Study has been collecting data since 2012 and data collection is ongoing. At the time of analysis, 95 centers were included in the Amyloid Biomarker Study. The study included 9746 individuals with normal cognition (NC) and 3023 participants with mild cognitive impairment (MCI) aged between 34 and 100 years for whom data on amyloid biomarkers, presence of depressive symptoms, and age were available. Data were analyzed from December 2022 to February 2024.Amyloid-β1-42 levels in cerebrospinal fluid or amyloid positron emission tomography scans were used to determine presence or absence of amyloid pathology. Presence of depressive symptoms was determined on the basis of validated depression rating scale scores, evidence of a current clinical diagnosis of depression, or self-reported depressive symptoms.In individuals with NC (mean [SD] age, 68.6 [8.9] years; 5664 [58.2%] female; 3002 [34.0%] APOE ε4 carriers; 937 [9.6%] had depressive symptoms; 2648 [27.2%] had amyloid pathology), the presence of depressive symptoms was not associated with amyloid pathology (odds ratio [OR], 1.13; 95% CI, 0.90-1.40; P = .29). In individuals with MCI (mean [SD] age, 70.2 [8.7] years; 1481 [49.0%] female; 1046 [44.8%] APOE ε4 carriers; 824 [27.3%] had depressive symptoms; 1668 [55.8%] had amyloid pathology), the presence of depressive symptoms was associated with a lower likelihood of amyloid pathology (OR, 0.73; 95% CI 0.61-0.89; P = .001). When considering subgroup effects, in individuals with NC, the presence of depressive symptoms was associated with a higher frequency of amyloid pathology in APOE ε4 noncarriers (mean difference, 5.0%; 95% CI 1.0-9.0; P = .02) but not in APOE ε4 carriers. This was not the case in individuals with MCI.Depressive symptoms were not consistently associated with a higher frequency of amyloid pathology in participants with NC and were associated with a lower likelihood of amyloid pathology in participants with MCI. These findings were not influenced by age, sex, or education level. Mechanisms other than amyloid accumulation may commonly underlie depressive symptoms in late life. |
| 536 | _ | _ | |a 353 - Clinical and Health Care Research (POF4-353) |0 G:(DE-HGF)POF4-353 |c POF4-353 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
| 650 | _ | 7 | |a Amyloid beta-Peptides |2 NLM Chemicals |
| 650 | _ | 7 | |a Biomarkers |2 NLM Chemicals |
| 650 | _ | 7 | |a Peptide Fragments |2 NLM Chemicals |
| 650 | _ | 7 | |a amyloid beta-protein (1-42) |2 NLM Chemicals |
| 650 | _ | 7 | |a Apolipoprotein E4 |2 NLM Chemicals |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 650 | _ | 2 | |a Female |2 MeSH |
| 650 | _ | 2 | |a Male |2 MeSH |
| 650 | _ | 2 | |a Aged |2 MeSH |
| 650 | _ | 2 | |a Depression |2 MeSH |
| 650 | _ | 2 | |a Middle Aged |2 MeSH |
| 650 | _ | 2 | |a Cross-Sectional Studies |2 MeSH |
| 650 | _ | 2 | |a Cognitive Dysfunction |2 MeSH |
| 650 | _ | 2 | |a Amyloid beta-Peptides: cerebrospinal fluid |2 MeSH |
| 650 | _ | 2 | |a Amyloid beta-Peptides: metabolism |2 MeSH |
| 650 | _ | 2 | |a Positron-Emission Tomography |2 MeSH |
| 650 | _ | 2 | |a Aged, 80 and over |2 MeSH |
| 650 | _ | 2 | |a Adult |2 MeSH |
| 650 | _ | 2 | |a Biomarkers: cerebrospinal fluid |2 MeSH |
| 650 | _ | 2 | |a Peptide Fragments: cerebrospinal fluid |2 MeSH |
| 650 | _ | 2 | |a Apolipoprotein E4: genetics |2 MeSH |
| 650 | _ | 2 | |a Age Factors |2 MeSH |
| 693 | _ | _ | |0 EXP:(DE-2719)DIAN-20090101 |5 EXP:(DE-2719)DIAN-20090101 |e Longitudinal Study on Dominantly Inherited Alzheimer's Disease |x 0 |
| 700 | 1 | _ | |a Oomens, Julie E |b 1 |
| 700 | 1 | _ | |a Engelborghs, Sebastiaan |b 2 |
| 700 | 1 | _ | |a Baeken, Chris |b 3 |
| 700 | 1 | _ | |a von Arnim, Christine A F |b 4 |
| 700 | 1 | _ | |a Boada, Mercè |b 5 |
| 700 | 1 | _ | |a Didic, Mira |b 6 |
| 700 | 1 | _ | |a Dubois, Bruno |b 7 |
| 700 | 1 | _ | |a Fladby, Tormod |b 8 |
| 700 | 1 | _ | |a van der Flier, Wiesje M |b 9 |
| 700 | 1 | _ | |a Frisoni, Giovanni B |b 10 |
| 700 | 1 | _ | |a Fröhlich, Lutz |b 11 |
| 700 | 1 | _ | |a Gill, Kiran Dip |b 12 |
| 700 | 1 | _ | |a Grimmer, Timo |b 13 |
| 700 | 1 | _ | |a Hildebrandt, Helmut |b 14 |
| 700 | 1 | _ | |a Hort, Jakub |b 15 |
| 700 | 1 | _ | |a Itoh, Yoshiaki |b 16 |
| 700 | 1 | _ | |a Iwatsubo, Takeshi |b 17 |
| 700 | 1 | _ | |a Klimkowicz-Mrowiec, Aleksandra |b 18 |
| 700 | 1 | _ | |a Lee, Dong Young |b 19 |
| 700 | 1 | _ | |a Lleó, Alberto |b 20 |
| 700 | 1 | _ | |a Martinez-Lage, Pablo |b 21 |
| 700 | 1 | _ | |a de Mendonça, Alexandre |b 22 |
| 700 | 1 | _ | |a Meyer, Philipp T |b 23 |
| 700 | 1 | _ | |a Kapaki, Elisabeth N |b 24 |
| 700 | 1 | _ | |a Parchi, Piero |b 25 |
| 700 | 1 | _ | |a Pardini, Matteo |b 26 |
| 700 | 1 | _ | |a Parnetti, Lucilla |b 27 |
| 700 | 1 | _ | |a Popp, Julius |b 28 |
| 700 | 1 | _ | |a Rami, Lorena |b 29 |
| 700 | 1 | _ | |a Reiman, Eric M |b 30 |
| 700 | 1 | _ | |a Rinne, Juha O |b 31 |
| 700 | 1 | _ | |a Rodrigue, Karen M |b 32 |
| 700 | 1 | _ | |a Sánchez-Juan, Pascual |b 33 |
| 700 | 1 | _ | |a Santana, Isabel |b 34 |
| 700 | 1 | _ | |a Sarazin, Marie |b 35 |
| 700 | 1 | _ | |a Scarmeas, Nikolaos |b 36 |
| 700 | 1 | _ | |a Skoog, Ingmar |b 37 |
| 700 | 1 | _ | |a Snyder, Peter J |b 38 |
| 700 | 1 | _ | |a Sperling, Reisa A |b 39 |
| 700 | 1 | _ | |a Villeneuve, Sylvia |b 40 |
| 700 | 1 | _ | |a Wallin, Anders |b 41 |
| 700 | 1 | _ | |a Wiltfang, Jens |0 P:(DE-2719)2811317 |b 42 |u dzne |
| 700 | 1 | _ | |a Zetterberg, Henrik |b 43 |
| 700 | 1 | _ | |a Ossenkoppele, Rik |b 44 |
| 700 | 1 | _ | |a Verhey, Frans R J |b 45 |
| 700 | 1 | _ | |a Vos, Stephanie J B |b 46 |
| 700 | 1 | _ | |a Visser, Pieter Jelle |b 47 |
| 700 | 1 | _ | |a Jansen, Willemijn J |b 48 |
| 700 | 1 | _ | |a group, Amyloid Biomarker Study |b 49 |e Collaboration Author |
| 700 | 1 | _ | |a Initiative, Alzheimer’s Disease Neuroimaging |b 50 |e Collaboration Author |
| 700 | 1 | _ | |a Alcolea, Daniel |b 51 |
| 700 | 1 | _ | |a Altomare, Daniele |b 52 |
| 700 | 1 | _ | |a Baiardi, Simone |b 53 |
| 700 | 1 | _ | |a Baldeiras, Ines |b 54 |
| 700 | 1 | _ | |a Bateman, Randall J |b 55 |
| 700 | 1 | _ | |a Blennow, Kaj |b 56 |
| 700 | 1 | _ | |a Bottlaender, Michel |b 57 |
| 700 | 1 | _ | |a den Braber, Anouk |b 58 |
| 700 | 1 | _ | |a van Buchem, Mark A |b 59 |
| 700 | 1 | _ | |a Byun, Min Soo |b 60 |
| 700 | 1 | _ | |a Cerman, Jirí |b 61 |
| 700 | 1 | _ | |a Chen, Kewei |b 62 |
| 700 | 1 | _ | |a Chipi, Elena |b 63 |
| 700 | 1 | _ | |a Day, Gregory S |b 64 |
| 700 | 1 | _ | |a Drzezga, Alexander |0 P:(DE-2719)2811239 |b 65 |u dzne |
| 700 | 1 | _ | |a Eckerström, Marie |b 66 |
| 700 | 1 | _ | |a Ekblad, Laura L |b 67 |
| 700 | 1 | _ | |a Epelbaum, Stéphane |b 68 |
| 700 | 1 | _ | |a Förster, Stefan |b 69 |
| 700 | 1 | _ | |a Fortea, Juan |b 70 |
| 700 | 1 | _ | |a Freund-Levi, Yvonne |b 71 |
| 700 | 1 | _ | |a Frings, Lars |b 72 |
| 700 | 1 | _ | |a Guedj, Eric |b 73 |
| 700 | 1 | _ | |a Hausner, Lucrezia |b 74 |
| 700 | 1 | _ | |a Hellwig, Sabine |b 75 |
| 700 | 1 | _ | |a Huey, Edward D |b 76 |
| 700 | 1 | _ | |a Jiménez-Bonilla, Julio F |b 77 |
| 700 | 1 | _ | |a Johnson, Keith A |b 78 |
| 700 | 1 | _ | |a Juaristi, Ane Iriondo |b 79 |
| 700 | 1 | _ | |a Kandimalla, Ramesh |b 80 |
| 700 | 1 | _ | |a Paraskevas, George |b 81 |
| 700 | 1 | _ | |a Kern, Silke |b 82 |
| 700 | 1 | _ | |a Kirsebom, Bjørn-Eivind S |b 83 |
| 700 | 1 | _ | |a Kornhuber, Johannes |b 84 |
| 700 | 1 | _ | |a Lagarde, Julien |b 85 |
| 700 | 1 | _ | |a Landau, Susan M |b 86 |
| 700 | 1 | _ | |a Legdeur, Nienke |b 87 |
| 700 | 1 | _ | |a Llibre Guerra, Jorge J |b 88 |
| 700 | 1 | _ | |a Maserejian, Nancy N |b 89 |
| 700 | 1 | _ | |a Marquié, Marta |b 90 |
| 700 | 1 | _ | |a Minatani, Shinobu |b 91 |
| 700 | 1 | _ | |a Morbelli, Silvia Daniela |b 92 |
| 700 | 1 | _ | |a Mroczko, Barbara |b 93 |
| 700 | 1 | _ | |a Ntanasi, Eva |b 94 |
| 700 | 1 | _ | |a de Oliveira, Catarina Resende |b 95 |
| 700 | 1 | _ | |a Olivieri, Pauline |b 96 |
| 700 | 1 | _ | |a Orellana, Adelina |b 97 |
| 700 | 1 | _ | |a Perrin, Richard J |b 98 |
| 700 | 1 | _ | |a Peters, Oliver |0 P:(DE-2719)2811024 |b 99 |u dzne |
| 700 | 1 | _ | |a Prabhakar, Sudesh |b 100 |
| 700 | 1 | _ | |a Ramakers, Inez H |b 101 |
| 700 | 1 | _ | |a Rodríguez-Rodriguez, Eloy |b 102 |
| 700 | 1 | _ | |a Ruiz, Agustín |b 103 |
| 700 | 1 | _ | |a Rüther, Eckart |b 104 |
| 700 | 1 | _ | |a Selnes, Per |b 105 |
| 700 | 1 | _ | |a Silva, Dina |b 106 |
| 700 | 1 | _ | |a Soininen, Hilkka |b 107 |
| 700 | 1 | _ | |a Spiru, Luiza |b 108 |
| 700 | 1 | _ | |a Takeda, Akitoshi |b 109 |
| 700 | 1 | _ | |a Teichmann, Marc |b 110 |
| 700 | 1 | _ | |a Tijms, Betty M |b 111 |
| 700 | 1 | _ | |a Teunissen, Charlotte E |b 112 |
| 700 | 1 | _ | |a Thompson, Loisa I |b 113 |
| 700 | 1 | _ | |a Vogelgsangs, Jonathan |b 114 |
| 700 | 1 | _ | |a Vöglein, Jonathan |0 P:(DE-2719)2811820 |b 115 |u dzne |
| 700 | 1 | _ | |a Waldemar, Gunhild |b 116 |
| 700 | 1 | _ | |a Wallin, Åsa K |b 117 |
| 700 | 1 | _ | |a Yannakoulia, Mary |b 118 |
| 700 | 1 | _ | |a Yi, Dahyun |b 119 |
| 700 | 1 | _ | |a Zettergren, Anna |b 120 |
| 773 | _ | _ | |a 10.1001/jamapsychiatry.2024.4305 |g Vol. 82, no. 3, p. 296 - |0 PERI:(DE-600)2698864-1 |n 3 |p 296 - 310 |t JAMA psychiatry |v 82 |y 2025 |x 2168-622X |
| 909 | C | O | |o oai:pub.dzne.de:277426 |p VDB |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 42 |6 P:(DE-2719)2811317 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 65 |6 P:(DE-2719)2811239 |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 99 |6 P:(DE-2719)2811024 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 115 |6 P:(DE-2719)2811820 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-353 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Clinical and Health Care Research |x 0 |
| 914 | 1 | _ | |y 2025 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b JAMA PSYCHIAT : 2022 |d 2024-12-13 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2024-12-13 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2024-12-13 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2024-12-13 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2024-12-13 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2024-12-13 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1180 |2 StatID |b Current Contents - Social and Behavioral Sciences |d 2024-12-13 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2024-12-13 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2024-12-13 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0130 |2 StatID |b Social Sciences Citation Index |d 2024-12-13 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2024-12-13 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2024-12-13 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2024-12-13 |
| 915 | _ | _ | |a IF >= 25 |0 StatID:(DE-HGF)9925 |2 StatID |b JAMA PSYCHIAT : 2022 |d 2024-12-13 |
| 920 | 1 | _ | |0 I:(DE-2719)1011202 |k AG Boecker |l Positron Emissions Tomography (PET) |x 0 |
| 920 | 1 | _ | |0 I:(DE-2719)1111015 |k Clinical Research (Munich) |l Clinical Research (Munich) |x 1 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-2719)1011202 |
| 980 | _ | _ | |a I:(DE-2719)1111015 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|